Geode Capital Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $9.7M | Sell |
438,352
-82,662
| -16% | -$1.66M | ﹤0.01% | 2506 |
|
|
2026
Q2 | $10.7M | Sell |
521,014
-63,193
| -11% | -$1.07M | ﹤0.01% | 2499 |
|
|
2026
Q1 | $9.29M | Buy |
584,207
+75,983
| +15% | +$1.65M | ﹤0.01% | 2423 |
|
|
2025
Q4 | $13.4M | Buy |
508,224
+6,553
| +1% | +$170K | ﹤0.01% | 2251 |
|
|
2025
Q3 | $11.3M | Sell |
501,671
-11,672
| -2% | -$240K | ﹤0.01% | 2348 |
|
|
2025
Q2 | $10.2M | Buy |
513,343
+8,105
| +2% | +$158K | ﹤0.01% | 2353 |
|
|
2025
Q1 | $8.54M | Sell |
505,238
-8,914
| -2% | -$152K | ﹤0.01% | 2388 |
|
|
2024
Q4 | $9.5M | Buy |
514,152
+11,283
| +2% | +$220K | ﹤0.01% | 2412 |
|
|
2024
Q3 | $10.9M | Buy |
502,869
+13,320
| +3% | +$298K | ﹤0.01% | 2326 |
|
|
2024
Q2 | $9.6M | Buy |
489,549
+17,168
| +4% | +$358K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $10.3M | Buy |
472,381
+9,621
| +2% | +$239K | ﹤0.01% | 2318 |
|
|
2023
Q4 | $13.4M | Buy |
462,760
+20,070
| +5% | +$537K | ﹤0.01% | 2159 |
|
|
2023
Q3 | $11.8M | Buy |
442,690
+30,183
| +7% | +$1.03M | ﹤0.01% | 2158 |
|
|
2023
Q2 | $15.3M | Buy |
412,507
+7,843
| +2% | +$273K | ﹤0.01% | 2040 |
|
|
2023
Q1 | $12.6M | Buy |
404,664
+9,134
| +2% | +$294K | ﹤0.01% | 2107 |
|
|
2022
Q4 | $11.8M | Sell |
395,530
-650
| -0.2% | -$23.3K | ﹤0.01% | 2144 |
|
|
2022
Q3 | $15.1M | Buy |
396,180
+13,222
| +3% | +$663K | ﹤0.01% | 1948 |
|
|
2022
Q2 | $20.9M | Buy |
382,958
+7,014
| +2% | +$385K | ﹤0.01% | 1741 |
|
|
2022
Q1 | $23.5M | Buy |
375,944
+1,733
| +0.5% | +$114K | ﹤0.01% | 1792 |
|
|
2021
Q4 | $37.6M | Buy |
374,211
+14,369
| +4% | +$1.26M | ﹤0.01% | 1515 |
|
|
2021
Q3 | $32.4M | Buy |
359,842
+23,963
| +7% | +$2.18M | ﹤0.01% | 1641 |
|
|
2021
Q2 | $31M | Buy |
335,879
+67,971
| +25% | +$5.43M | ﹤0.01% | 1678 |
|
|
2021
Q1 | $25.9M | Buy |
267,908
+71,596
| +36% | +$7.39M | ﹤0.01% | 1708 |
|
|
2020
Q4 | $10.2M | Buy |
196,312
+40,933
| +26% | +$1.71M | ﹤0.01% | 2170 |
|
|
2020
Q3 | $6.22M | Sell |
155,379
-858
| -0.5% | -$26.9K | ﹤0.01% | 2265 |
|
|
2020
Q2 | $2.5M | Buy |
156,237
+59,131
| +61% | +$905K | ﹤0.01% | 2721 |
|
|
2020
Q1 | $1.04M | Buy |
97,106
+3,313
| +4% | +$46.1K | ﹤0.01% | 3005 |
|
|
2019
Q4 | $1.21M | Buy |
93,793
+63,020
| +205% | +$749K | ﹤0.01% | 3212 |
|
|
2019
Q3 | $319K | Buy |
+30,773
| New | +$292K | ﹤0.01% | 3625 |
|
|
2017
Q2 | – | Sell |
-15,051
| Closed | -$164K | – | 4091 |
|
|
2017
Q1 | $164K | Buy |
15,051
+1,238
| +9% | +$14.6K | ﹤0.01% | 3712 |
|
|
2016
Q4 | $159K | Buy |
+13,813
| New | +$130K | ﹤0.01% | 3688 |
|
Other funds holding FLGT
Geode Capital Management's FLGT Position: Q3 2026 in Review
Geode Capital Management reduced its Fulgent Genetics (FLGT) stake by 16% in Q3 2026, selling an estimated $1.66M and leaving 438,352 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2506.
Geode Capital Management first reported a position in FLGT in Q4 2016 and has held it in 31 quarters since. The position peaked at $37.6M in Q4 2021. 96 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Geode Capital Management held 438,352 shares of Fulgent Genetics worth $9.7M as of Q3 2026.
- Geode Capital Management sold 82,662 Fulgent Genetics shares in Q3 2026, an estimated $1.66M.
- Fulgent Genetics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2506 holding.
- Geode Capital Management first reported a position in Fulgent Genetics in Q4 2016 and has held it in 31 quarters since.
- Geode Capital Management's Fulgent Genetics position peaked at $37.6M in Q4 2021.
- 96 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.